Exciting new developments in whole-capsule compounding are on the horizon from P&C’s collaboration with CHU-Sainte Justine in Montréal, Canada. We have embarked on ground-breaking research using whole-capsules in the compounding of hazardous drugs. Specifically, the team at CHU-Sainte Justine is exploring the use of QuartetRx® in the compounding of liquid formulations of two hazardous compounds: hydroxyurea and tacrolimus. Preliminary data suggest that QuartetRx® provides a viable system for compounding using whole capsules. Stability data associated with these compounds and the QuartetRx® process are expected to be published in 2019.
– CHU-Sainte Justine in Montreal, CA